Al-Obaedi O Mr - Search Results

Year	Number of Results
2013	4
2014	6
2015	4
2016	3
2017	1
2018	5
2020	1
2021	1
2022	6
2023	7
2024	1

1

Al-Obaidi MM, Tanriover B, Zangeneh TT. Al-Obaidi MM, et al. Am J Med. 2024 Feb;137(2):e42. doi: 10.1016/j.amjmed.2023.10.016. Am J Med. 2024. PMID: 38296411 No abstract available.

2

Race and ethnicity: Risk factors for fungal infections?

Jenks JD, Aneke CI, Al-Obaidi MM, Egger M, Garcia L, Gaines T, Hoenigl M, Thompson GR 3rd. Jenks JD, et al. Among authors: al obaidi mm. PLoS Pathog. 2023 Jan 5;19(1):e1011025. doi: 10.1371/journal.ppat.1011025. eCollection 2023 Jan. PLoS Pathog. 2023. PMID: 36602962 Free PMC article. Review.

3

Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients.

Zangeneh TT, Al-Obaidi MM. Zangeneh TT, et al. Among authors: al obaidi mm. J Fungi (Basel). 2023 Apr 26;9(5):513. doi: 10.3390/jof9050513. J Fungi (Basel). 2023. PMID: 37233224 Free PMC article. Review.

4

Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system.

Al-Obaidi MMJ, Bahadoran A, Wang SM, Manikam R, Raju CS, Sekaran SD. Al-Obaidi MMJ, et al. Acta Virol. 2018;62(1):16-27. doi: 10.4149/av_2018_102. Acta Virol. 2018. PMID: 29521099 Review.

5

Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Al-Obaidi MMJ, Desa MNM. Al-Obaidi MMJ, et al. Cell Mol Neurobiol. 2018 Oct;38(7):1349-1368. doi: 10.1007/s10571-018-0609-2. Epub 2018 Aug 16. Cell Mol Neurobiol. 2018. PMID: 30117097 Review.

6

The Utility of (1→3)-β-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients.

Al-Obaidi MM, Ayazi P, Shi A, Campanella M, Connick E, Zangeneh TT. Al-Obaidi MM, et al. J Fungi (Basel). 2022 Jul 25;8(8):768. doi: 10.3390/jof8080768. J Fungi (Basel). 2022. PMID: 35893136 Free PMC article.

7

Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant Recipients.

Al-Obaidi MM, Nematollahi S, Nix DE, Zangeneh TT. Al-Obaidi MM, et al. Clin Infect Dis. 2022 May 30;74(10):1885-1886. doi: 10.1093/cid/ciab878. Clin Infect Dis. 2022. PMID: 34738618 No abstract available.

8

Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action.

Hoenigl M, Sprute R, Arastehfar A, Perfect JR, Lass-Flörl C, Bellmann R, Prattes J, Thompson GR 3rd, Wiederhold NP, Al Obaidi MM, Willinger B, Arendrup MC, Koehler P, Oliverio M, Egger M, Schwartz IS, Cornely OA, Pappas PG, Krause R. Hoenigl M, et al. Among authors: al obaidi mm. Expert Opin Investig Drugs. 2022 Aug;31(8):795-812. doi: 10.1080/13543784.2022.2086120. Epub 2022 Jun 15. Expert Opin Investig Drugs. 2022. PMID: 35657026 Free PMC article.

9

Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region.

Zangeneh TT, Lainhart WD, Wiederhold NP, Al-Obaidi MM. Zangeneh TT, et al. Among authors: al obaidi mm. Med Mycol. 2023 Oct 5;61(10):myad104. doi: 10.1093/mmy/myad104. Med Mycol. 2023. PMID: 37804176

10

Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic.

Streling AP, Al Obaidi MM, Lainhart WD, Zangeneh T, Khan A, Dinh AQ, Hanson B, Arias CA, Miller WR. Streling AP, et al. Among authors: al obaidi mm. Clin Infect Dis. 2021 Dec 6;73(11):e4472-e4474. doi: 10.1093/cid/ciaa1909. Clin Infect Dis. 2021. PMID: 33411899 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year